Context: Morphological characteristics of the glucose curve during an oral glucose tolerance test (OGTT) (time to peak and shape) may reflect different phenotypes of insulin secretion and action, but their ability to predict diabetes risk is uncertain.
| INTRODUCTION
Prediabetes significantly increases the risk for developing diabetes and is independently associated with higher mortality rates.
1
Established screening guidelines, using fasting and 2-hour glucose thresholds derived from the oral glucose tolerance test (OGTT), 2, 3 are effective for diagnosing prediabetes, but the predictive ability may vary by race/ethnicity and incidence of diabetes in the population. 4, 5 Up to 10%-30% of individuals who developed diabetes were normoglycaemic on initial evaluation. [6] [7] [8] Yet impaired insulin secretion relative to insulin resistance is a fundamental pathophysiologic feature in normoglycaemic individuals at highest risk for disease progression 9 and highlights the need for enhancing diabetes risk prediction models.
10
Assessing the morphological characteristics of the glucose curve (eg time to glucose peak and curve shape) during an OGTT could be a useful indicator of prediabetes risk because it may reflect different phenotypes of insulin secretion relative to insulin sensitivity. Recently, the monophasic shape has been proposed as a risk predictor for β-cell function and diabetes in adults, 11-14 children [15] [16] [17] and pregnant women. 18 Yet there is heterogeneity in the glucose curve shape 13 ; consistent shape characterization is poorly reproducible 19 and varies with duration of the OGTT. 14 In contrast, the time to maximal glucose peak was the most reproducible parameter in a study of healthy volunteers that evaluated five morphological features of the OGTT glucose curve (time to insulin peak, shape of the glucose curve, glucose nadir below baseline, 1-hour postchallenge glucose and time to glucose peak). 20 In normoglycaemic insulin sensitive individuals, the time to glucose peak commonly occurred at or before 30 minutes [21] [22] [23] and a later time to glucose peak (≥60 minutes) was observed in adults with type 2 diabetes.
21
These data suggest the close physiological relationship between β-cell function and morphological characteristics of the OGTT. Yet, glucose curve shape has several limitations which may limit its widespread use for risk stratification. Therefore, we characterized the glucose response curve during an OGTT using these two morphological parameters and compared the ability of each parameter to detect prediabetes and β-cell function relative to insulin sensitivity in adults without diabetes. 
| MATERIALS AND METHODS

| Study population and design
2.
Shape of the glucose curve was characterized as biphasic or monophasic as previously described. 13 Curves were classified as monophasic if glucose increased to a maximum between 30 and 90 minutes followed by a decrease until 120 minutes. 13 Curves were classified as biphasic if glucose peaked at 30 or 60 minutes, followed by a nadir and second peak by 120 minutes. Prior to shape classification, the upward or downward change in glucose between time points was defined as a glucose difference of >0.22 mmol/L. This value was based on the upper limit of the coefficient of variation of glucose samples run at the NIH Clinical Center laboratory. One individual whose glucose curve increased monotonically was categorized as "Unclassified" and was excluded from further group analysis.
| Calculations and variables
| Assessment of insulin sensitivity and β-cell function
The insulin sensitivity index (S I ) was determined by the minimal model (MinMOD Millenium v.6.02). 25 β-cell function was determined in two ways: (i) the acute insulin response to glucose (AIRg), calculated as the area under the insulin curve above basal between 0 and 10 minutes, and (ii) the disposition index (DI), calculated as S I ×AIRg.
| Analyses
Glucose concentrations were measured in serum using an enzymatic hexokinase assay on the Cobas 6000 instrument (Roche Diagnostics, Indianapolis, IN, USA). Insulin and C-peptide were measured in serum via electrochemiluminescence on the Cobas 6000 instrument (Roche Diagnostics). Haemoglobin A1c was determined by HPLC-D10 instrument (Bio-Rad Laboratories, Hercules CA, USA) in 144 patients because one patient had hereditary persistence of foetal haemoglobin, and HbA1c could not be determined. Total percent body fat was determined using whole-body dual-energy X-ray absorptiometry (DXA) scans (Hologic Discovery, Bedford, MA, USA).
| Modelling changes in morphological parameters of OGTT in a hypothetical subject
A longitudinal-dynamic (differential equation) model for whole-body glucose and insulin homoeostasis 26 was used to simulate a hypothetical subject prone to glucose intolerance. The model was used as a tool to simulate OGTTs at 3 times points (baseline, 2 and 5 years) and assess the changes in the glucose curve shape and time to glucose peak along the progression to diabetes. Details of the model are provided in the Supplemental materials.
| Statistical analyses
Data are presented as mean±SD, except where otherwise indicated.
The area under the curves (AUC) during the 2-hour OGTT for glucose, insulin and C-peptide were calculated using the trapezoid rule. Within- (Table  S1) Prediabetes was diagnosed in 36% (52/145) of participants and was associated with older age, higher haemoglobin A1c, higher fasting and 2-hour glucose concentrations. Otherwise, there were no differences in race/ethnicity, sex, BMI or other physical characteristics in those with and without prediabetes. (Table 1) 
| RESULTS
| Prediabetes in the cross-sectional cohort
| Glucose curve classification by time to glucose peak vs curve shape
| Physical and metabolic characteristics by morphology of glucose curve
| Time to glucose peak
Glucose peak >30 minutes was associated with older age (P=.03),
higher BMI (P=.02), greater percent body fat (P=.04), larger waist circumference (P=.03), higher rates of prediabetes (P<.001) and higher overall glycaemia during the OGTT (P<.01). Fasting and 2-hour Cpeptide, and 2-hour insulin were higher in the group with glucose peak >30 minutes (P<.01).
| Shape of the glucose curve
The monophasic curve was more common in individuals with a family history of diabetes (Table 1) . Otherwise, there were no differences in physical characteristics such as age, sex, BMI or body composition between participants with a monophasic vs biphasic curve. Fasting glucose, insulin and C-peptide concentrations and rates of prediabetes were similar in individuals with monophasic and biphasic curves.
Individuals with a monophasic curve had higher 2-hour and AUC concentrations for glucose, insulin and C-peptide (P=.01).
To account for potential sex differences in the relationships with metabolic characteristics, we repeated the analyses using only women or men and found no differences in the results (data not shown).
| Relationship of morphology of glucose curve to β-cell function (Figure 2)
Figure 2 depicts the Tukey box and whisker plots for S I , AIRg and DI by morphology of the glucose curve. A glucose peak >30 minutes was associated with significantly lower AIRg (~25%), and DI (~50%) with a trend for lower S I (~20%) (Figure 2A-C) . The monophasic vs biphasic curve was associated with lower DI (~30%) but no difference in S I or AIRg ( Figure 2D-F) .
The relative contribution of the two morphological parameters to DI is shown in 
| Relationship of morphology of glucose curve to prediabetes
In the unadjusted logistic regression, glucose peak >30 minutes was associated with a fourfold increased odds of prediabetes (OR: 4.0; .01 The sensitivity and specificity for detecting prediabetes in individuals with glucose peak>30 minutes were 84% and 43%, respectively.
Individuals with a monophasic curve had a sensitivity and specificity for detecting prediabetes of 75% and 36%, respectively. The ROC AUC for prediabetes tended to be higher for the parameter glucose 
| Dynamic-longitudinal modelling-simulated OGTTs in a hypothetical subject
The simulations of glucose curves during the progression to diabetes in a hypothetical subject showed that with time and worsening of hyperglycaemia, the glucose peak progressively shifted to the right, remained monophasic and was associated with greater glucose AUC F I G U R E 2 Tukey box and whiskers plot of the relationship of time to glucose peak with S I (A), AIRg (B), disposition index (C) and glucose curve shape with S I (D), AIRg (E) and disposition index (F) (Fig. S1 ). The delay in the timing of the glucose peak with progression to diabetes coincided with ~60% lower S I and ~60% and ~80% lower β-cell function at 2 and 5 years, respectively (Fig. S1 ).
| DISCUSSION
This comparative analysis highlights the limitations of using the glucose curve shape parameter and provides additional evidence to support the time to glucose peak parameter as a potential prediabetes risk stratification tool. The time to glucose peak >30 minutes was an independent indicator of prediabetes and lower β-cell function in an otherwise healthy multi-ethnic adult cohort. A later time to glucose peak was associated with a worse metabolic profile during the OGTT (Table 1 ) and higher odds of prediabetes (OR: 4.0, P<.001). Using a reliable measure of β-cell function relative to insulin sensitivity, glucose peak >30 minutes was associated with lower DI, even after adjusting for glucose AUC during the OGTT (Table 2) . Therefore, the association of time to glucose peak with β-cell function was independent of overall glycaemia during the OGTT and suggests that this parameter could be used in addition to glucose thresholds in risk prediction models. Moreover, our findings highlight the limitations of using glucose curve shape as a screening tool for prediabetes. The monophasic curve was not associated with increased odds for prediabetes (Table 2 ) and tended to have a lower ability to detect prediabetes (ROC AUC) compared to the glucose peak parameter.
Additional support for the dynamic nature of the time to glucose peak compared to the curve shape was provided by the dynamiclongitudinal model. 26 The simulations predicted that the failure of β-cell function and mass to compensate for insulin resistance was reflected in differences in both time to glucose peak and glucose AUC in OGTTs simulated at various time points during the progression to diabetes (Fig. S1 ). In contrast, glucose curve shape remained monophasic with no shift observed as hyperglycaemia worsened. In the model, both the decline in S I and the loss of β-cell function contributed to the shift in the time to glucose peak. This model observation is consistent with the strong association between DI and time to glucose peak in our clinical observations.
The monophasic curve was proposed as a useful predictor of prediabetes because of its association with lower DI (derived from clamp indices 27 ) and ~2-fold increase in progression to type 2 diabetes over a 7-to 8-year period. 12 Compared to the biphasic curve, the monophasic shape was linked to a worse cardiometabolic profile among adults and children. [12] [13] [14] [15] 27 However, the monophasic curve may have low sensitivity for identifying individuals at high risk for prediabetes because it is ubiquitous and up to 20% of participants could not be easily characterized into a monophasic or biphasic shape category. 14 More recently, the monophasic curve was found to be poorly reproducible and associated with significant heterogeneity in 70% of individuals over a 3-year period. 19 The marked variability in curve shape was independent of glucose tolerance status, although a persistent curve shape was associated with higher odds for impaired fasting glucose. The limited predictive ability of the monophasic shape for impaired glucose tolerance 19 is further compounded by its co-linearity with overall glycaemia. 28 In our study, only one individual could not be easily classified as monophasic or biphasic. Nevertheless, curve shape did not differentiate physical and metabolic risk groups (Table 1 ) and tended to have lower sensitivity and specificity for prediabetes when compared to the time to peak parameter. As the relationship of curve shape with lower β-cell function was mediated by overall glycaemia (Table 2) , this further limits its use as a glucose independent risk factor.
In contrast, time to glucose peak was a strong predictor of β-cell function in our multi-ethnic population at high risk for diabetes, one third of whom already had prediabetes. Our findings are in agreement with cross-sectional analyses that have linked later time to glucose peak with impaired glucose tolerance and type 2 diabetes. 20, 21 The predictive ability of the time to glucose peak parameter is further demonstrated by a longitudinal analysis in 532 postpartum predominantly white women. 29 Compared to an unchanged glucose peak, both a shift in the glucose peak to a later time point and an unchanged glucose peak at ≥60 minutes were associated with declining insulin secretion and worsening glucose tolerance over a 9-month period. The dynamic nature of the time to glucose peak coincided with changes in 2-hour glucose values in normal glucose tolerant women and provided insight into early changes in β-cell function. We now extend these observations to African immigrant, African American and white overweight/ obese men and women who were otherwise healthy. Additional analyses are necessary to determine whether time to glucose peak could be a valuable epidemiological tool of β-cell function in populations with Using the multiple sampled OGTT to characterize the time to glucose peak could also maximize the predictive value for cardiovascular disease. A recent meta-analysis of >1200 nondiabetic individuals identified cardiovascular risk was related to the timing and the height of the glucose peak. 35 Moreover, the time of the glucose peak may be dynamic with the potential to assess changes in β-cell function relative to insulin sensitivity. Kramer et al. 20 evaluated the oral disposition index in 63 patients with type 2 diabetes who were treated with shortterm insulin therapy and demonstrated that the time to glucose peak shifted to an earlier time point in those with improved β-cell function.
The strength of this analysis is that reliable and independent measures of pancreatic function were used to test the ability of a simple parameter to aid in clinical and epidemiological evaluations of prediabetes risk. However, there are a few notable limitations. Our cross-sectional analysis in predominantly African descent individuals will require validation in a larger longitudinal study to assess whether this tool can be used to advise primary prevention guidelines for type 2 diabetes. Further, the reproducibility of the time to glucose peak parameter could be influenced by variations in gastric emptying or differences in pretest carbohydrate loading. These factors were not assessed in the current study but would be informative in future evaluations of OGTT risk predictors. Of note, assessing the time to glucose peak parameter requires a multiple sample OGTT, while only two sampling time points (fasting and 2-hour glucose) are currently recommended for the diagnosis of prediabetes. The additional advantage of testing glucose levels at 30, 60 and 90 minutes would be the ability to obtain a measure of β-cell function without increasing the time commitment of the patient and with a marginal increase in cost.
In conclusion, using a multiple sample 2-hour OGTT, the time to glucose peak is a stronger independent indicator of prediabetes and β-cell function than glucose curve shape. The glucose peak parameter maximizes the information obtained from a single OGTT and could prove to be a valuable tool of high clinical and epidemiological significance because it can be simply derived and used in addition to glycaemic thresholds to enhance prediabetes risk stratification.
